Cargando…

Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma

Background: Piperacillin (Pip)/tazobactam (Taz) is a broad-spectrum antimicrobial agent that has been commonly used in the intensive care unit for severe and life-threatening infections. Recent evidence suggests that therapeutic drug monitoring (TDM) for Pip could be beneficial in clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelkawy, Khaled, Le, Tyson, Mahmoud, Sherif Hanafy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952387/ https://www.ncbi.nlm.nih.gov/pubmed/36830231 http://dx.doi.org/10.3390/antibiotics12020321

Ejemplares similares

Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
por: Yang, Jihyun, et al.
Publicado: (2023)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

DRESS syndrome induced by piperacillin-tazobactam
por: Sanchez-Gonzalez, Maria-Jose, et al.
Publicado: (2014)

Tazobactam and piperacillin-induced thrombocytopenia: A case report
por: CHEN, HONG, et al.
Publicado: (2016)

Enterobacter endophthalmitis: Treatment with intravitreal tazobactam- piperacillin
por: Singh, Trehan Hemant, et al.
Publicado: (2007)

Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Piperacillin–tazobactam as alternative to carbapenems for ICU patients
por: Pilmis, Benoit, et al.
Publicado: (2017)

Piperacillin/tazobactam: Eosinophilic-pneumonia: case report
Publicado: (2021)

1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019)

An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
por: Wallenburg, Eveline, et al.
Publicado: (2022)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
por: Kyriakou, Aikaterini, et al.
Publicado: (2019)

Meropenem/piperacillin/tazobactam: Drug resistance: case report
Publicado: (2021)

Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy
por: Workum, J D, et al.
Publicado: (2020)

Piperacillin/tazobactam/vancomycin: Cast nephropathy: case report
Publicado: (2022)

Piperacillin/tazobactam: Acute eosinophilic pneumonia: case report
Publicado: (2021)

Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy
por: Wong, Jane CY, et al.
Publicado: (2020)

612. Pharmacokinetics of Piperacillin-Tazobactam in Patients with Severe Infections
por: Rodríguez-Báez, Ana S, et al.
Publicado: (2022)

Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility
por: Martin Mena, Anthony, et al.
Publicado: (2023)

Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
por: Wallenburg, Eveline, et al.
Publicado: (2022)

A Simple Sample Preparation with HPLC-UV Method for Estimation of Clomipramine from Plasma
por: Mostafavi, Sayed Abolfazl, et al.
Publicado: (2010)

Interference by piperacillin/tazobactam in the measurement of creatinine with the Jaffe method and of total protein with the biuret method
por: Dimeski, Goce, et al.
Publicado: (2023)

Drug Fever Due to Piperacillin/Tazobactam Loaded into Bone Cement
por: Park, Hyun Bum, et al.
Publicado: (2011)

Cefoxitin vs. Piperacillin/Tazobactam for Acute Appendicitis in Pediatric Patients
por: Paek, Hana, et al.
Publicado: (2017)

Hematologic Adverse Effects of Prolonged Piperacillin-Tazobactam Use in Adults
por: Benli, Aysun, et al.
Publicado: (2018)

Piperacillin/tazobactam: Increased liver function tests: case report
Publicado: (2020)

Piperacillin–tazobactam induced bicytopenia in low cumulative treatment doses
por: Chen, Chien-Chou, et al.
Publicado: (2019)

Piperacillin/tazobactam/vancomycin: Clostridium difficile colitis: case report
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin–Tazobactam in Obese Patients
por: Veillette, John J., et al.
Publicado: (2021)

Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay
por: Ho, Yi-Hsin, et al.
Publicado: (2018)

Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary?
por: Kunicki, Paweł K., et al.
Publicado: (2021)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
por: Chachanidze, Vladimir, et al.
Publicado: (2009)

Piperacillin/tazobactam administered by continuous or intermittent infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2009)

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam
por: Rodriguez, Carlos A., et al.
Publicado: (2016)

Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections
por: Kim, Yong Kyun, et al.
Publicado: (2016)

Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
por: Kerkhoff, Andrew D., et al.
Publicado: (2017)

2407. Emerging Piperacillin/Tazobactam Resistance in Escherichia coli and Klebsiella sp.
por: Suseno, Mira, et al.
Publicado: (2018)

Autism and Piperacillin-tazobactam-induced Hypersensitivity Vasculitis: A Silent Malady
por: Kolli, Sindhura, et al.
Publicado: (2019)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iro9tj1bg7ub95jstaqubkj5fn